Recursion Pharmaceuticals (RXRX) PT Raised to $15 at KeyBanc
Tweet
Share
E-mailGet Alerts RXRX Hot Sheet
Price: $3.31 --0%
Rating Summary:
4 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 11 | New: 8
Rating Summary:
4 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 11 | New: 8
Join SI Premium – FREE
KeyBanc analyst Scott Schoenhaus raised the price target on Recursion Pharmaceuticals (NASDAQ: RXRX) to $15.00 (from $12.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Bullish (BLSH) PT Raised to $30 at Compass Point
- OptimumBank Holdings (OPHC) PT Raised to $10.50 at Compass Point
- StubHub Holdings (STUB) PT Lowered to $11 at Mizuho
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
